APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches

APOE ε4 allele remains strongest genetic risk factor for sporadic Alzheimer's disease and APOE ε2 allele strongest genetic protective factor after multiple large scale genome-wide association studies/meta-analyses, however, no therapies directed at APOE are currently available.

Source:

The Lancet Neurology